| A Study in Indian Postmenopausal Women With Osteoporosis to Evaluate the Efficacy and Safety of Denosumab (NCT01495000) | GlaxoSmithKline | 2012-01-01 |
| A Study of Intravenous Zanamivir in the Treatment of Hospitalized Patients With Influenza Infection (NCT01527110) | GlaxoSmithKline | 2012-01-01 |
| Special Drug Use Investigation for Arixtra® (Fondaparinux) Venous Thromboembolism Treatment (NCT01428531) | GlaxoSmithKline | 2012-01-01 |
| Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry. (NCT01498679) | GlaxoSmithKline | 2012-01-01 |
| Japanese phase1 Study of Belimumab (IV vs SC) (NCT01516450) | GlaxoSmithKline | 2011-12-26 |
| Bioequivalence Study to Compare Fluticasone Furoate (FF) 1-strip Inhaler With FF 2-strip Inhaler and With FF/Vilanterol Combination (NCT01485445) | GlaxoSmithKline | 2011-12-21 |
| A Study to Evaluate Single and Repeat Doses of IV GSK2251052 in Healthy Male Japanese and Caucasian Subjects and Repeat Doses of Supratherapeutic Doses of IV GSK2251052 in Healthy Volunteers (NCT01495065) | GlaxoSmithKline | 2011-12-19 |
| QTc Study GSK573719+GW642444 (NCT01521377) | GlaxoSmithKline | 2011-12-19 |
| A Two Cohort Study to Look at the Metabolites of GSK221149, the Metabolism of GSK221149 Administered With a High Fat Meal and With Ketoconazole (NCT01627587) | GlaxoSmithKline | 2011-12-12 |
| Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Pneumococcal Vaccine 2830930A Administered in Toddlers (NCT01485406) | GlaxoSmithKline | 2011-12-12 |
| Pharmacokinetic (PK) Profiles of Tenofovir Disoproxil Fumarate (TDF) 300 mg in Healthy Chinese Subjects (NCT01480622) | GlaxoSmithKline | 2011-12-05 |
| Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B With Poor Response to Other Drugs (NCT01475851) | GlaxoSmithKline | 2011-12-01 |
| Type II Diabetes Mellitus in Patients Exposed to Pravastatin and Paroxetine (NCT01602913) | GlaxoSmithKline | 2011-12-01 |
| A Comparison of Atorvastatin and Glimepiride Fixed Dose Combination and Atorvastatin and Glimepiride Loose Combination in the Treatment of Patients With Type 2 Diabetes Mellitus (NCT01495013) | GlaxoSmithKline | 2011-12-01 |
| Evaluation of Specific Biomarkers in Primary Invasive Breast Cancer (NCT01476111) | GlaxoSmithKline | 2011-12-01 |
| Albiglutide Glucose Clamp Study in Subjects With Type 2 Diabetes (NCT01475734) | GlaxoSmithKline | 2011-12-01 |
| A Study in Cancer Patients to Evaluate the Effect of Lapatinib on the QTc Interval (NCT01328054) | GlaxoSmithKline | 2011-12-01 |
| WEUKBRE5557: IMI PROTECT(Work Package 2): Antiepileptics & Suicide (NCT01607333) | GlaxoSmithKline | 2011-12-01 |
| Effect of Haemodialysis on the Pharmacokinetics of Ezogabine/Retigabine and Its N-acetyl Metabolite (NCT01480609) | GlaxoSmithKline | 2011-11-30 |
| A Repeat Dose Study in Healthy Volunteers Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK356278 (NCT01573819) | GlaxoSmithKline | 2011-11-24 |
| Pilot Study of Patient's Adherence to TYKERB™/TYVERB™ + Capecitabine in Metastatic Breast Cancer (NCT01462604) | GlaxoSmithKline | 2011-11-23 |
| A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of an Intravenous Infusion of GW328267X in Healthy Volunteers (NCT01640990) | GlaxoSmithKline | 2011-11-22 |
| Healthy Volunteer Positron Emission Tomography (PET) Brain Occupancy Study of a Phosphodiesterase 4 (PDE4) Inhibitor in Huntington's Disease (NCT01602900) | GlaxoSmithKline | 2011-11-22 |
| Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Human Papillomavirus (HPV) Vaccine (GSK-580299) and Merck's Gardasil Vaccine When Administered According to Alternative 2-dose Schedules in 9-14 Year Old Females (NCT01462357) | GlaxoSmithKline | 2011-11-21 |
| SAS115359: A 6-month Study to Assess the Safety and Benefit of Inhaled Fluticasone Propionate/Salmeterol Combination Compared With Inhaled Fluticasone Propionate in the Treatment of Adolescents and Adults (12 Years of Age and Older) With Asthma. (NCT01475721) | GlaxoSmithKline | 2011-11-18 |
| Study to Evaluate Immunogenicity of the Hepatitis B Antigen of the GSK Biologicals' Candidate Malaria Vaccine (257049) (NCT01345240) | GlaxoSmithKline | 2011-11-17 |
| 6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old (NCT01462344) | GlaxoSmithKline | 2011-11-17 |
| Assessment of Comorbidities in Chronic Obstructive Pulmonary Disease (COPD) in European Symptomatic Subjects From Primary Care (NCT01516528) | GlaxoSmithKline | 2011-11-17 |
| Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in Adults With TB Disease (NCT01424501) | GlaxoSmithKline | 2011-11-14 |
| An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease (NCT01536418) | GlaxoSmithKline | 2011-11-11 |
| A Phase I/IIa, First Time in Human, Study of GSK2636771 in Subjects With Advanced Solid Tumors With Phosphatase and Tensin Homolog (PTEN) Deficiency (NCT01458067) | GlaxoSmithKline | 2011-11-10 |
| A Study to Determine the Safety, Tolerability, and Effects of GSK2374697 in Healthy Volunteers (NCT01545570) | GlaxoSmithKline | 2011-11-07 |
| A Study Assessing a Range of Formulations of the Fixed Dose Combination Product Containing Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) to Find a Formulation Which is Bioequivalent to Harnal-D Tablets (Tamsulosin Hydrochloride, 0.2mg) in Healthy Male Subjects From North East Asia (NCT01495026) | GlaxoSmithKline | 2011-11-06 |
| A Study to Evaluate the Bioequivalence of a Combined Formulated Tablet Compared With Maraviroc and Combivir™ (NCT01597648) | GlaxoSmithKline | 2011-11-01 |
| Study on the Incidence of Intussusception (IS) in Children Aged < 12 Months in Japan (NCT01479491) | GlaxoSmithKline | 2011-11-01 |
| WEUKBRE5555: IMI PROTECT(Work Package 2): Liver Injury & Antibiotics (NCT01587768) | GlaxoSmithKline | 2011-11-01 |
| Special Drug Use Investigation for LAMICTAL Bipolar (NCT01428518) | GlaxoSmithKline | 2011-11-01 |
| IMI PROTECT(WP2): Antidepressants & Fractures (NCT01587729) | GlaxoSmithKline | 2011-11-01 |
| A Study in Korean Postmenopausal Women With Osteoporosis to Evaluate the Efficacy and Safety of Denosumab (NCT01457950) | GlaxoSmithKline | 2011-11-01 |
| Evaluation of Efficacy of Experimental Gel to Foam Dentifrices in Dental Erosion (NCT01657903) | GlaxoSmithKline | 2011-11-01 |
| IMI PROTECT (Work Package 2): Calcium Channel Blockers and Cancer (NCT01587742) | GlaxoSmithKline | 2011-11-01 |
| A Study of GSK2110183 in Subjects With Proteasome Inhibitor Refractory Multiple Myeloma (NCT01445587) | GlaxoSmithKline | 2011-11-01 |
| A Study to Test the Ability of and Safety of GSK2110183 in Treating Langerhans Cell Histiocytosis (NCT01395004) | GlaxoSmithKline | 2011-11-01 |
| Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B Untreated With Nucleic Acid Analogue (NCT01480284) | GlaxoSmithKline | 2011-11-01 |
| Study of a New Thermo Stable Formulation of Epoprostenol Sodium to Treat Pulmonary Arterial Hypertension (PAH) (NCT01462565) | GlaxoSmithKline | 2011-11-01 |
| WEUKBRE5559: IMI PROTECT: Benzodiazepines & Fracture (NCT01587833) | GlaxoSmithKline | 2011-11-01 |
| Provoked Craving Relief Study by NRT (NCT01476202) | GlaxoSmithKline | 2011-11-01 |
| Ofatumumab Subcutaneous Administration in Subjects With Relapsing-Remitting Multiple Sclerosis (NCT01457924) | GlaxoSmithKline | 2011-11-01 |
| Effects of Two Doses of a Common Cold Treatment on Alertness (NCT01686646) | GlaxoSmithKline | 2011-11-01 |
| An Adaptive Phase I Study to Evaluate the Safety, Efficacy and Dose Responses of Ronacaleret in Healthy Human Volunteers (NCT01466335) | GlaxoSmithKline | 2011-10-27 |
| A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD) (NCT01462292) | GlaxoSmithKline | 2011-10-26 |
| A Study of the Safety and Activity of the MEK Inhibitor Given Together With the AKT Inhibitor to Patients With Multiple Myeloma or Solid Tumor Cancers (NCT01476137) | GlaxoSmithKline | 2011-10-26 |
| A Four Part Study to Investigate Relative Bioavailability, Safety and Tolerability of up to 5 Oral Formulation of GSK2251052 in Order to Identify a Formulation for Further Evaluation in a Future Later Phase Study (NCT01702350) | GlaxoSmithKline | 2011-10-21 |
| The Safety, Tolerability, PK and PD of GSK2339345 in Healthy Subjects (NCT01494636) | GlaxoSmithKline | 2011-10-17 |
| Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744) (NCT01453998) | GlaxoSmithKline | 2011-10-14 |
| SAP Depleter Dose Assessment Study in Patients (NCT01406314) | GlaxoSmithKline | 2011-10-13 |
| A Study to Look at How GSK1325756 is Taken up by the Body When Given by Mouth When Stomach Acid is Reduced (NCT01453478) | GlaxoSmithKline | 2011-10-12 |
| Assessment of Lung Function After Single Inhalations of a Bronchodilator From 2 Configurations a Dry Powder Inhaler. (NCT01521390) | GlaxoSmithKline | 2011-10-12 |
| Gabapentin and Donepezil Combination on Experimental Human Pain Models (NCT01485185) | GlaxoSmithKline | 2011-10-11 |
| GSK2251052 in the Treatment of Complicated Intra-abdominal Infections (NCT01381562) | GlaxoSmithKline | 2011-10-03 |
| Airflow Limitation in Cardiac Diseases in Europe (NCT01485159) | GlaxoSmithKline | 2011-10-01 |
| A Phase 2a Study to Evaluate the Effect of Rilapladib (SB-659032) in Alzheimer's Disease (NCT01428453) | GlaxoSmithKline | 2011-10-01 |
| A Phase II, Randomized, Open-label Study of Lapatinib Plus Chemotherapy Versus Trastuzumab Plus Chemotherapy in HER2-positive and p95HER2-positive Metastatic Breast Cancer (NCT01137994) | GlaxoSmithKline | 2011-10-01 |
| Immunogenicity and Safety Study of Booster Dose of GSK Biologicals' IPV (Poliorix™) and DTPa/Hib (Infanrix+Hib™) Vaccine (NCT01449812) | GlaxoSmithKline | 2011-10-01 |
| Inhaled Fluticasone Furoate/Vilanterol Safety and Tolerability, PK and PD Study (NCT01453023) | GlaxoSmithKline | 2011-10-01 |
| SB-480848 in Major Adverse Cardiovascular Events - Integrated Summary of Efficacy and Safety From the STABILITY Trial (LPL100601) and the SOLID-TIMI-52 Trial (SB-480848/033) (NCT01636271) | GlaxoSmithKline | 2011-10-01 |
| An Efficacy Study of GlaxoSmithKline (GSK) Biologicals' Candidate Influenza Vaccine GSK2321138A in Children (NCT01439360) | GlaxoSmithKline | 2011-10-01 |
| A Study of Immunogenicity and Safety of GSK Biologicals' Influenza Vaccine FLU-Q-QIV in Adults Aged 18 Years and Older (NCT01440387) | GlaxoSmithKline | 2011-09-30 |
| Effect of Omeprazole and Ritonavir on GSK2336805 Pharmacokinetics in Healthy Adults (NCT01458054) | GlaxoSmithKline | 2011-09-27 |
| Study STF115287, a Clinical Confirmation Study of GSK2585823 in the Treatment of Acne Vulgaris in Japanese Subjects (NCT01445301) | GlaxoSmithKline | 2011-09-27 |
| Post-marketing Study to Assess the Safety of CERVARIX When Used in the United States and in Canada (NCT01290393) | GlaxoSmithKline | 2011-09-26 |
| A Single Oral Escalating Dose Study of GSK2140944 in Healthy Volunteers (NCT02202187) | GlaxoSmithKline | 2011-09-26 |
| A Study to Investigate the Effect of GSK1605786 on Hepatic Cytochrome P450, and BCRP and OATP1B1 Transport in Healthy Adult Subjects (NCT01489943) | GlaxoSmithKline | 2011-09-19 |
| A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Oral and Intravenous GSK1322322 in Healthy Subjects (NCT01610388) | GlaxoSmithKline | 2011-09-13 |
| Exploratory Lapatinib (Positron Emission Tomography) PET Study in Subjects With Breast Cancer (NCT01290354) | GlaxoSmithKline | 2011-09-12 |
| Gynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study Subjects (NCT01190176) | GlaxoSmithKline | 2011-09-12 |
| Multiple Doses of Anti-NOGO A in Relapsing Forms of Multiple Sclerosis (NCT01435993) | GlaxoSmithKline | 2011-09-08 |
| Study to Evaluate the Incidence, Clinical Characteristics and Economic Burden of Dengue in Brazilian Children (NCT01391819) | GlaxoSmithKline | 2011-09-06 |
| Open Label Study of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (NCT01480245) | GlaxoSmithKline | 2011-09-01 |
| Clinical Study of Lamotrigine to Treat Newly Diagnosed Typical Absence Seizure in Children and Adolescents (NCT01431976) | GlaxoSmithKline | 2011-09-01 |
| Cross-Over Study to Assess the Cardiovascular Effects of GSK2336805 (NCT01424540) | GlaxoSmithKline | 2011-09-01 |
| Clinical Study of Lamotrigine to Treat Newly Diagnosed Epilepsy (NCT01431963) | GlaxoSmithKline | 2011-09-01 |
| Pilot Study to Investigate the Efficacy of a Toothpaste in Providing Relief From Dentinal Hypersensitivity (NCT01494649) | GlaxoSmithKline | 2011-09-01 |
| Observational Study on Rotavirus Gastroenteritis Epidemiology, Impact of Lyophilised vs. Liquid Formulation of Rotarix™ (NCT01435967) | GlaxoSmithKline | 2011-09-01 |
| Evaluating the Efficacy and Safety of Fluticasone Furoate in the Treatment of Asthma in Adults and Adolescents (NCT01431950) | GlaxoSmithKline | 2011-09-01 |
| Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma (NCT01436071) | GlaxoSmithKline | 2011-09-01 |
| Cardiovascular Events in Parkinson's Disease Patients (NCT01545856) | GlaxoSmithKline | 2011-09-01 |
| Bupropion & Cardio Birth Defect (Slone) (NCT01597661) | GlaxoSmithKline | 2011-09-01 |
| An Open-label Study of GSK1120212 Compared With Docetaxel in Stage IV KRAS-mutant Non-small Cell Lung Cancer (NCT01362296) | GlaxoSmithKline | 2011-09-01 |
| Influenza Burden Assessment in the United Kingdom, 1996-2008 (NCT01520935) | GlaxoSmithKline | 2011-09-01 |
| Phase IV Observational Study in Chronic Lymphocytic Leukemia (NCT01453062) | GlaxoSmithKline | 2011-09-01 |
| Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma (NCT01436110) | GlaxoSmithKline | 2011-09-01 |
| Provoked Craving Assessment (NCT01506908) | GlaxoSmithKline | 2011-09-01 |
| Assessment of the Pharmacokinetics of GSK1278863 and Metabolites in Normal Subjects and Subjects With Renal Impairment (NCT01406340) | GlaxoSmithKline | 2011-08-30 |
| Bioequivalence Study for an Isotretinoin (NCT01863615) | GlaxoSmithKline | 2011-08-26 |
| To Investigate the Effect of Intravenous Ondansetron on Cardiac Conduction as Compared to Placebo and Moxifloxacin in Healthy Adult Subjects (NCT01449188) | GlaxoSmithKline | 2011-08-16 |
| Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Monovalent Pandemic H5N1 Vaccine in Adults (NCT01416571) | GlaxoSmithKline | 2011-08-12 |
| LRRK2 Mutation and Parkinson's Disease (NCT01424475) | GlaxoSmithKline | 2011-08-11 |
| Safety, Immunogenicity and Efficacy Against of a Combined Malaria Vaccine in Healthy Malaria-naïve Adults (NCT01366534) | GlaxoSmithKline | 2011-08-10 |
| Japanese Phase 1 Study of Mepolizumab (NCT01471327) | GlaxoSmithKline | 2011-08-09 |